https://www.pharmaceutical-technology.com/data-insights/amarin-corp-gets-grant-for-reducing-heart-failure-risk-using-eicosapentaenoic-acid/
Discover Amarin Corp's groundbreaking patent for reducing heart failure risk in statin users through targeted eicosapentaenoic acid supplementation. Learn more!
amarin corpeicosapentaenoic acidheart failurepatentrisk